Literature DB >> 8550573

The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2.

L C Platanias1, S Uddin, A Yetter, X J Sun, M F White.   

Abstract

Binding of interferon alpha (IFN alpha) to its receptor induces activation of the Tyk-2 and Jak-1 tyrosine kinases and tyrosine phosphorylation of multiple downstream signaling elements, including the Stat components of the interferon-stimulated gene factor 3 (ISGF-3). IFN alpha also induces tyrosine phosphorylation of IRS-1, the principle substrate of the insulin receptor. In this study we demonstrate that various Type I IFNs rapidly stimulate tyrosine phosphorylation of IRS-2. This is significant since IRS-2 is the major IRS protein found in hematopoietic cells. The IFN alpha-induced phosphorylated form of IRS-2 associates with the p85 regulatory subunit of the phosphatidylinositol 3'-kinase, suggesting that this kinase participates in an IFN alpha-signaling cascade downstream of IRS-2. We also provide evidence for an interaction of IRS-2 with Tyk-2, suggesting that Tyk-2 is the kinase that phosphorylates this protein during IFN alpha stimulation. A conserved region in the pleckstrin homology domain of IRS-2 may be required for the interaction of IRS-2 with Tyk-2, as shown by the selective binding of glutathione S-transferase (GST) fusion proteins containing the IRS-2-IH1PH or IRS-1-IH1PH domains to Tyk-2 but not other Janus kinases in vitro.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550573     DOI: 10.1074/jbc.271.1.278

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.

Authors:  L M Shaw
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype.

Authors:  S Tanaka; J R Wands
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 3.  IFNs-signaling effects on lung cancer: an up-to-date pathways-specific review.

Authors:  Vasiliki Galani; Michalis Kastamoulas; Anna Varouktsi; Evangeli Lampri; Antigoni Mitselou; Dimitrios L Arvanitis
Journal:  Clin Exp Med       Date:  2016-07-14       Impact factor: 3.984

4.  Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells.

Authors:  Simrit Parmar; Jessica Smith; Antonella Sassano; Shahab Uddin; Efstratios Katsoulidis; Beata Majchrzak; Suman Kambhampati; Elizabeth A Eklund; Martin S Tallman; Eleanor N Fish; Leonidas C Platanias
Journal:  Blood       Date:  2005-03-24       Impact factor: 22.113

5.  The role of glycogen synthase kinase 3 in regulating IFN-β-mediated IL-10 production.

Authors:  Huizhi Wang; Jonathan Brown; Carlos A Garcia; Yunan Tang; Manjunatha R Benakanakere; Terrance Greenway; Pascale Alard; Denis F Kinane; Michael Martin
Journal:  J Immunol       Date:  2010-12-15       Impact factor: 5.422

Review 6.  Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells.

Authors:  Adam T Waickman; Jonathan D Powell
Journal:  J Immunol       Date:  2012-05-15       Impact factor: 5.422

7.  Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling.

Authors:  Surinder Kaur; Antonella Sassano; Ajith M Joseph; Beata Majchrzak-Kita; Elizabeth A Eklund; Amit Verma; Saskia M Brachmann; Eleanor N Fish; Leonidas C Platanias
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  Suppression of interferon (IFN)-inducible genes and IFN-mediated functional responses in BCR-ABL-expressing cells.

Authors:  Efstratios Katsoulidis; Antonella Sassano; Beata Majchrzak-Kita; Nathalie Carayol; Patrick Yoon; Alison Jordan; Brian J Druker; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2008-02-20       Impact factor: 5.157

Review 9.  mTOR, metabolism, and the regulation of T-cell differentiation and function.

Authors:  Adam T Waickman; Jonathan D Powell
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

10.  Innate immunity in pluripotent human cells: attenuated response to interferon-β.

Authors:  Xiao-Xiao Hong; Gordon G Carmichael
Journal:  J Biol Chem       Date:  2013-04-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.